accountdefinitive asset purchase agreement to sell its neoprobe ��� GDS line of gamma detection device systems to Devicor Medical Products, Inc. (Devicor) for $30 million in cash, plus a contingent value provision for payment to Neoprobe of up to an additional...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Neoprobe Announces Sale Of Gamma Detection Device Business To Devicor Medical Products
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account